(Q48263349)

10 February 2018

title

Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats (English)

1 reference

10 February 2018

1 reference

5

T Unger

1 reference

10 February 2018

J Culman

1

1 reference

10 February 2018

C von Heyer

series ordinal

2

1 reference

10 February 2018

B Piepenburg

series ordinal

3

1 reference

10 February 2018

W Rascher

series ordinal

4

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

10 February 2018

European Journal of Pharmacology

published in

1 reference

10 February 2018

volume

367

1 reference

10 February 2018

issue

2-3

1 reference

10 February 2018

page(s)

255-265

1 reference

10 February 2018

Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

A new formalin test allowing simultaneous evaluation of cardiovascular and nociceptive responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Central DuP 753 does not lower blood pressure in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Role of AT1 receptors in the central control of sympathetic vasomotor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Angiotensin receptors in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Distribution of angiotensin type-1 receptor messenger RNA expression in the adult rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. An immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

On making multiple comparisons in clinical and experimental pharmacology and physiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Repeated measurements and multiple comparisons in cardiovascular research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Deficits in drinking and vasopressin secretion after lesions of the nucleus medianus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Distribution of angiotensin II receptor subtypes in rat brain nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Projections from the subfornical organ to the supraoptic nucleus in the rat: ultrastructural identification of an interposed synapse in the median preoptic nucleus using a combination of neuronal tracers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Increased angiotensin II binding affinity in the nucleus tractus solitarius of spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Vasopressin in the plasma of stroke-prone spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Access of peripherally administered DuP 753 to rat brain angiotensin II receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Mapping of angiotensin II receptor subtype heterogeneity in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Effects of chemical stimulation of the subfornical organ on metabolic activity of the hypothalamo-neurohypophysial system in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Differential effects of central angiotensin II and substance P on sympathetic nerve activity in conscious rats. Implications for cardiovascular adaptation to behavioral responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

Increased concentration of angiotensin II binding sites in selected brain areas of spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Brain angiotensin in the developing spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900983-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00983-2

1 reference

10 February 2018

1 reference

10 February 2018